These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4934418)

  • 1. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 3. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A; Cisternas H; Torres MC; Alliende ME
    Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042
    [No Abstract]   [Full Text] [Related]  

  • 6. Diet and drugs in the treatment of hyperlipidemias.
    Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S; Nizzola GM
    Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038
    [No Abstract]   [Full Text] [Related]  

  • 10. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
    JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 12. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term therapy of ischaemic heart disease.
    Dewar HA
    Arzneimittelforschung; 1972 Oct; 22(10):1835-40. PubMed ID: 4630017
    [No Abstract]   [Full Text] [Related]  

  • 14. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of essential hyperlipidaemia.
    Fredrickson DS; Levy RI
    Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etofibrate and clofibrate in double blind study].
    Rahlfs VW; Zimmermann H; Safer A
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1168-9. PubMed ID: 789039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.